Business policy & strategy management

790 views

Published on

Different Marketing Models used. Comparison of Twos Pharma companies and strategies adopt by the companies..

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
790
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
30
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Business policy & strategy management

  1. 1. Business Policy & Strategy Management Presented By: Rahul Pawar 012003 Philomen Prem 012010 Sanjeev Kumar 012015 Mayur Gupta 012018 Jayesh Raut 012023 Swapnil Rathore 012025 Abhishek Ayarkar 012031 Pawan Sharma 012035 Khandu Chaudhari 012040 Submitted to : VISHAL SIR9/30/2013 1
  2. 2. Companies and Products: Arflur-D-Gel Arflur-D-Gel 9/30/2013 2
  3. 3. Freedom of choice- Wide spectrum of Therapeutic segments to choose from. Dedication to serve- Highest quality standards with latest technology at affordable prices. Care for all- Always committed towards better healthcare solutions. Vision: Expanding Health Horizons... 9/30/2013 3
  4. 4. Core Values: 1. Synergy 2. Trust 3. Competitiveness 4. Openness 5. Integrity 6. Discipline 7. Creativity 8. Quest for excellence 9/30/2013 4
  5. 5. FDC Ltd Arflur-D-Gel Category - Analgesic Gel (pain killer gel) Price- ₹46/30gm Competitors: - Volini & Volitra Gel from Ranbaxy, Omini Gel from Cipla 9/30/2013 5
  6. 6. 9/30/2013 6 Mission: - Achieving customer satisfaction is fundamental to our business. - Provide products and services of the higher quality. - Ensure profitable growth and enhance wealth of shareholders. - Manage our operation with high concern for safety and environment. - Be a responsible corporate citizen. Objective: At Ranbaxy, we make good health affordable and accessible to the local communities and society at large.
  7. 7. Business Level Strategies: FDC: RANBAXY: 9/30/2013 7 Product Differentiation Cost Focus: Target Customers Arflur-D-Gel
  8. 8. FDC : • Ranbaxy: 9/30/2013 8CONCLUSION:
  9. 9. Comparison both the companies with its Drugs using Porter's 5 Forces: 9/30/2013 9Conclusion:
  10. 10. Comparison both the companies with its Drugs using Generic Value Chain: 9/30/2013 10
  11. 11. Retrenchment: • Arflur-D-Gel • Launched 3yrs Back • Less Growth • Less Awareness • Volini-Gel • Launched 10yrs Back • High Growth Rate • Everyone Knows 9/30/2013 11
  12. 12. Integration: FDC Limited: • With a modest beginning in 1936 - marketing vitamins and a range of prescription formulations - FDC set up its first formulations manufacturing facility in 1949. • This shows that FDC follows Backward Integration. 9/30/2013 12 Ranbaxy: It started as a Distributor in 1937. In 1951, Ranbaxy started manufacturing with Italian Company Lepitit. It shows its backward Integration.
  13. 13. BCG Matrix High Low High Low B U S I N E S S G R O W T H R A T E Market Share 13 Star Product
  14. 14. Conclusion: • Though Ranbaxy and F.D.C both are MNC still the companies have there own strategies. • As discussed all models proves that Ranbaxy stands far better than FDC with its product Volini. 9/30/2013 14
  15. 15. 9/30/2013 15

×